MQS Management’s Pfizer PFE Stock Holding History

MQS Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$484K	Buy	+20,082	New	+$525K	0.59%	35
2026 Q1	–	Sell	-15,434	Closed	-$384K	–	540
2025 Q4	$384K	Buy	+15,434	New	+$389K	0.23%	183
2025 Q2	–	Sell	-23,773	Closed	-$602K	–	608
2025 Q1	$602K	Buy	+23,773	New	+$622K	0.35%	78
2024 Q4	–	Sell	-13,853	Closed	-$401K	–	303
2024 Q3	$401K	Buy	+13,853	New	+$404K	0.22%	190
2023 Q2	–	Sell	-13,261	Closed	-$541K	–	561
2023 Q1	$541K	Buy	+13,261	New	+$573K	0.35%	75

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

MQS Management's PFE Position: Q2 2026 in Review

MQS Management opened a new position in Pfizer (PFE) in Q2 2026: 20,082 shares worth $484K. The stake represents 0.59% of the portfolio and ranks #35 among its holdings. This is a return to the name: MQS Management previously reported a position in PFE as recently as Q4 2025.

MQS Management first reported a position in PFE in Q1 2023 and has held it in 5 quarters since. The position peaked at $602K in Q1 2025. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

MQS Management held 20,082 shares of Pfizer worth $484K as of Q2 2026.
Pfizer was a new MQS Management position in Q2 2026.
Pfizer made up 0.59% of MQS Management's portfolio in Q2 2026, its #35 holding.
MQS Management first reported a position in Pfizer in Q1 2023 and has held it in 5 quarters since.
MQS Management's Pfizer position peaked at $602K in Q1 2025.
2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on MQS Management's 13F filing for Q2 2026, filed 7 Aug 2026.